MORPHOSYS revenue breakdown overview

MORPHOSYS revenue for the last year amounted to 238.30 M EUR, the most of which — 238.28 M EUR — came from its highest performing source at the moment, Innovative Cancer Medicines, the year earlier bringing 278.27 M EUR. The greatest contribution to the revenue figure was made by United States — last year it brought MORPHOSYS 211.48 M EUR.